MF Press
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 26
- HER2/EGFR in Cancer Research 19
- Cancer Treatment and Pharmacology 9
-
- Advanced Breast Cancer Therapies 11
- Co-authors
- M S Mitchell (1 shared paper)MC Pike (1 shared paper)Laurence N. Kolonel (1 shared paper)Brian E. Henderson (1 shared paper)Roberta McKean‐Cowdin (1 shared paper)D G Kieback (3 shared papers)RS Finn (4 shared papers)Michael Arbushites (6 shared papers)
- Journals
- Cancer Research (11 papers)Journal of Clinical Oncology (10 papers)International Journal of Gynecological Cancer (1 paper)Tumor Biology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
MF Press
29 papers receiving 282 citations
Peers
Comparison fields: 5 of 34
- Oncology 212
- Cancer Research 63
- Radiology, Nuclear Medicine and Imaging 90
- Immunology and Allergy 15
- Reproductive Medicine 16
Countries citing papers authored by MF Press
This map shows the geographic impact of MF Press's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MF Press with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MF Press more than expected).
Fields of papers citing papers by MF Press
This network shows the impact of papers produced by MF Press. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MF Press. The network helps show where MF Press may publish in the future.
Co-authors
The 25 scholars most cited alongside MF Press, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The role of immunohistochemistry and fluorescence in situ hybridization for HER2/neu in assessing the prognosis of breast cancer. | 1999 | 79 |
| 2 | Germ-line HER-2 variant and breast cancer risk by stage of disease. | 2001 | 37 |
| 3 | 2011 | 35 | |
| 4 | 2018 | 21 | |
| 5 | Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor. | 1993 | 18 |
| 6 | 2009 | 13 | |
| 7 | Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL). | 1994 | 12 |
| 8 | 2018 | 10 | |
| 9 | 2017 | 9 | |
| 10 | 2008 | 8 | |
| 11 | 2005 | 7 | |
| 12 | 2014 | 6 | |
| 13 | 2005 | 4 | |
| 14 | 2008 | 4 | |
| 15 | 2009 | 3 | |
| 16 | 2008 | 3 | |
| 17 | 2009 | 2 | |
| 18 | 2010 | 2 | |
| 19 | 2009 | 2 | |
| 20 | 2008 | 2 |
About MF Press
MF Press is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Molecular Biology, having authored 30 papers that have together received 288 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (19 papers), Advanced Breast Cancer Therapies (11 papers), Cancer Treatment and Pharmacology (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Breast Cancer Treatment Studies (6 papers), Estrogen and related hormone effects (4 papers), Ovarian cancer diagnosis and treatment (3 papers) and Advanced Biosensing Techniques and Applications (3 papers). The work is most often cited by research in Oncology (212 citations), Cancer Research (63 citations), Radiology, Nuclear Medicine and Imaging (90 citations), Immunology and Allergy (15 citations) and Reproductive Medicine (16 citations). MF Press has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include M S Mitchell, MC Pike, Laurence N. Kolonel, Brian E. Henderson, Roberta McKean‐Cowdin, D G Kieback, RS Finn, Michael Arbushites, Tanja Fehm and Dennis J. Slamon. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, International Journal of Gynecological Cancer, Tumor Biology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.